First-line third-generation EGFR-TKIs for advanced EGFR-mutated non-small cell lung cancer: a systematic review and network meta-analysis of randomized controlled trials.

Tagrisso (osimertinib) - AstraZeneca

Semena (befotertinib) - InventisBio, Betta Pharma

Rui Bi Da (rezivertinib) - Beta Pharma

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

Lazcluze (lazertinib) - J&J

Ivesa (firmonertinib) - Allist, ArriVent

Sanrisso (rilertinib) - Nanjing Sanhome Pharma

limertinib (ASK120067) - Aosaikang Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42444976

Jinglong Chen; Qingfang Zhao; Wei Sun; Xiaomin Liu

Jul 15, 2026